CambridgeSoft

edit

CambridgeSoft Corporation is a leading supplier of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company provides:

Enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively.

CambridgeSoft’s products are used primarily in the pharmaceutical, biotechnology and chemical industries, as well as in higher education and in academic and government research. The company’s principal software offering, Chem & Bio Office, which includes Chem & Bio Draw, is the de facto standard and primary communication tool on the chemist’s desktop. Chem & Bio Office Enterprise, an enterprise implementation of Chem & Bio Office desktop, enables research information organizations to deploy application and information solutions using Internet, intranet, and extranet technologies

Milestones

edit

• Received $21M in Unattributed funding. (7/21/08)
  Posted 6/22/09 at 4:31am
• Michael C. Rubenstein, Vice President, Development and CTO added.
  Posted 6/22/09 at 4:31am
• Michael G. Tomasic, President and CEO added.
  Posted 6/22/09 at 4:31am
• James T. Reilly, Vice President, Finance and CFO added.
  Posted 6/22/09 at 4:31am

Videos

Screenshots

edit

Above: Home
Uploaded: 6/22/09

Sources

1. CambridgeSoft announces $21M Investment by Goldman Sachs (cambridgesoft.com) [edit]